Categories Uncategorized

Researchers Find That Disrupted Sleep Could Result in Early Death

A recent study has found a clear link between a higher risk of dying from illnesses of the heart and blood vessels and the duration and frequency of unconscious wakefulness throughout night-time sleep.

The researchers discovered that in comparison with the general female population, women who underwent unconscious wakefulness for long periods of time had a higher risk of dying from a cardiovascular ailment. The research findings were reported in the “European Heart Journal.”

The study, which had 8,001 male and female participants, could not find a clear link in males as their cardiovascular death risk only grew by a quarter when compared to the general male population.

The researchers describe unconscious wakefulness as a normal part of sleep. It is also referred to as cortical arousal and is said to occur rather spontaneously. It’s part of the ability of an individual’s body to respond to situations that could possibly be dangerous, such as breathing becoming obstructed. Other triggers include noise, light, temperature, trauma, limb movements and pain.

An associate professor for the cardiology department at the Maastricht University Medical Center, Dominik Linz explained that while an individual may consciously become aware of their environment, depending on the strength of the arousal, which usually doesn’t happen. This is why, despite the sleep fragmentation, individuals may feel tired or exhausted in the morning but will not be cognizant of the arousals.

Prior research has demonstrated that sleep duration, whether too long or too short, is linked to a higher risk of death from cardiovascular illnesses as well as other causes.

This recent research was conducted in collaboration with a group of researchers from the University of Adelaide’s School of Electrical and Electronic Engineering. The group was led by Associate professor Matthias Baumert.

The researchers examined data obtained from sleep monitors worn throughout the night by women and men who had taken part in three separate studies, including the Sleep Heart Health Study, the Study of Osteoporotic Fractures and the Osteoporotic Fractures in Men Sleep Study. The participants were followed up for a period of six to eleven years.

Linz noted that it was unclear why there was a difference between women and men in the associations but speculated that the body’s response to arousal or triggers that caused an arousal could explain the increased risk of cardiovascular death in women. He added that advising patients to practice good sleep hygiene while also minimizing noise pollution at night could help decrease the arousal burden.

The research spotlight isn’t only being put on complications resulting from sleep disruptions. Other companies are looking into different health complications, and Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) has succeeded in designing techniques and technology that can help clinicians get a better view of cancerous tissues during surgical procedures.

NOTE TO INVESTORS: The latest news and updates relating to Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) are available in the company’s newsroom at https://ibn.fm/IMEXF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

1 day ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

3 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

3 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

4 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago